Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The drug name refers to a specific multimodal analgesic intervention protocol evaluated by Diskapi Teaching and Research Hospital for the management of acute postoperative pain in patients undergoing lumbar disc surgery. This intervention consists of an ultrasound-guided erector spina plane (ESP) block using the local anesthetic **bupivacaine**, combined with systemic analgesia provided via intravenous patient-controlled analgesia (IV-PCA) using **tramadol**. The ESP block is a regional anesthesia technique where local anesthetic is injected into the fascial plane deep to the erector spinae muscle, targeting the dorsal rami of spinal nerves to provide regional analgesia. This combination therapy aims to reduce postoperative pain scores, decrease total opioid consumption, and prolong the time to the first analgesic requirement compared to standard IV-PCA alone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bupivacaine + tramadol (Dışkapı Yıldırım Beyazıt Training and Research Hospital).